1. Home
  2. SWKH vs SGHT Comparison

SWKH vs SGHT Comparison

Compare SWKH & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SWK Holdings Corporation

SWKH

SWK Holdings Corporation

HOLD

Current Price

$16.70

Market Cap

198.4M

Sector

Finance

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$3.88

Market Cap

187.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWKH
SGHT
Founded
1996
2011
Country
United States
United States
Employees
9
N/A
Industry
Diversified Financial Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
198.4M
187.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SWKH
SGHT
Price
$16.70
$3.88
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$18.00
$9.08
AVG Volume (30 Days)
18.8K
235.0K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
N/A
$77,363,000.00
Revenue This Year
N/A
$11.67
Revenue Next Year
N/A
$10.39
P/E Ratio
$9.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.00
$2.40
52 Week High
$18.40
$9.24

Technical Indicators

Market Signals
Indicator
SWKH
SGHT
Relative Strength Index (RSI) 32.19 48.49
Support Level $14.69 $3.29
Resistance Level $17.08 $4.29
Average True Range (ATR) 0.37 0.19
MACD -0.05 0.09
Stochastic Oscillator 12.06 69.80

Price Performance

Historical Comparison
SWKH
SGHT

About SWKH SWK Holdings Corporation

SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: